{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "15701300",
  "DateCompleted": {
    "Year": "2008",
    "Month": "02",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "11",
    "Day": "09"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1534-312X",
      "JournalIssue": {
        "Volume": "7",
        "Issue": "1",
        "PubDate": {
          "Year": "2005",
          "Month": "Feb"
        }
      },
      "Title": "Current gastroenterology reports",
      "ISOAbbreviation": "Curr Gastroenterol Rep"
    },
    "ArticleTitle": "What you need to know about GB virus C.",
    "Pagination": {
      "StartPage": "54",
      "EndPage": "62",
      "MedlinePgn": "54-62"
    },
    "Abstract": {
      "AbstractText": [
        "GB virus C (GBV-C) is a nonpathogenic member of the Flaviviridae family most closely related to hepatitis C virus (HCV). Infection is common in healthy and immunocompromised people and may persist for years. GBV-C infection is associated with improved survival, improved AIDS-free survival, higher CD4(+) T-cell counts, and lower HIV viral loads in HIV-infected people compared with people infected with HIV but not GBV-C. The mechanism of this effect is not yet clear, but GBV-C has been shown to inhibit HIV replication in vitro through increased synthesis and secretion of anti-HIV b-chemokines MIP-1a, MIP-1b, RANTES, SDF-1, and SDF-2 and downregulation of CCR5 receptor expression. GBV-C also inhibits apoptosis of its host cell, similar to HCV. GBV-C E2 protein in serum has also been associated with prolonged survival in HIV infection; recent evidence indicates that GBV-C E2 protein may neutralize HIV infection in vitro."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Infectious Diseases, Saint Louis University School of Medicine, FDT-8N, 3635 Vista Avenue, St. Louis, MO 63110, USA. georgesl@slu.edu"
          }
        ],
        "LastName": "George",
        "ForeName": "Sarah L",
        "Initials": "SL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Varmaz",
        "ForeName": "Dino",
        "Initials": "D"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Curr Gastroenterol Rep",
    "NlmUniqueID": "100888896",
    "ISSNLinking": "1522-8037"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "epidemiology",
        "immunology"
      ],
      "DescriptorName": "AIDS-Related Opportunistic Infections"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Antiretroviral Therapy, Highly Active"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "epidemiology",
        "immunology"
      ],
      "DescriptorName": "Flaviviridae Infections"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "GB virus C"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "epidemiology",
        "immunology"
      ],
      "DescriptorName": "Hepatitis, Viral, Human"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunocompromised Host"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Incidence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Liver Function Tests"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Randomized Controlled Trials as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Assessment"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Severity of Illness Index"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Survival Analysis"
    }
  ],
  "NumberOfReferences": "54"
}